Corrections

Bevacizumab for the treatment of neovascular age related macular degeneration

BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c3681 (Published 08 July 2010) Cite this as: BMJ 2010;341:c3681

In this editorial by Usha Chakravarthy (BMJ 2010;340:c2834, doi:10.1136/bmj.c2834) the final sentence of the first paragraph should have stated: “Tufail and colleagues report their findings from the ABC Trial, a multicentre randomised controlled study that compared the use of bevacizumab and usual care” [not “bevacizumab and ranibizumab”].

Notes

Cite this as: BMJ 2010;341:c3681

View Abstract